The Association for Professionals in Infection Control and Epidemiology (APIC) announces that Mary Lou Manning, PhD, CRNP, CIC, FAPIC, FSHEA, FAAN, professor at the Thomas Jefferson University and former APIC president, will be honored with the Carol DeMille Achievement Award for her visionary le
Sarah Krein, PhD, RN, research career scientist at the Veterans Affairs (VA) Ann Arbor Center for Clinical Management Research, and professor at the University of Michigan, will be honored with the 2019 Distinguished Scientist Award from the Association for Professionals in Infection Control and
The Association for Professionals in Infection Control and Epidemiology (APIC) announces that Brian Harte, MD, MHM, president of Cleveland Clinic Akron General, will be the recipient of the 2019 Healthcare Administrator Award.
Marc-Oliver Wright, MT(ASCP), MS, CIC, FAPIC, clinical infection control practitioner at the University of Wisconsin Hospitals and Clinics, will be honored with the 2019 President’s Distinguished Service Award from the Association for Professionals in Infection Control and Epidemiology (APIC).
The Food and Drug Administration (FDA) announces it has authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood.
La Jolla Institute professor Erica Ollmann Saphire, PhD, will lead a five-year global effort totaling up to $35 million that brings together experts from around the world to streamline and accelerate the development of immunotherapeutics against emerging and re-emerging viral threats.
The Food and Drug Administration (FDA) has permitted marketing of the Synovasure Lateral Flow Test Kit as an aid for the detection of periprosthetic joint infection (infection around a joint replacement) in the synovial (lubricant) fluid of patients being evaluated for revision surgery, which is
The Food and Drug Administration (FDA) announces it has cleared for marketing two tests that can detect the presence of the bacteria Chlamydia trachomatis and Neisseria gonorrhoeae, which cause the sexually-transmitted infections, respectively, chlamydia and gonorrhea, through diagnostic testing
An estimated 2 million people become infected with bacteria that are resistant to antibiotics each year in the United States.
The Food and Drug Administration (FDA) announces the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in ende